← Eichor
Condition: Lung Inflammation Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Lung Inflammation

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Impact of Capillaroscopy in the Investigation of Diffuse Interstitial Pneumonias
NA · 1 location(s) · University Hospital, Bordeaux · NCT07283081Efficacy and Safety of YD0743 Treatment for Sepsis-Associated ARDS
Phase 2 · 1 location(s) · Shanghai Yidian Pharmaceutical Technology Development Co., L · NCT07413094HO-1/CREB3 Modulates Golgi Stress in Patients With Sepsis
Phase N/A · 1 location(s) · Tianjin Nankai Hospital · NCT06045780Retrospective Analysis of Chest X-ray Severity Scoring System of COVID-19 Pneumonia
Phase N/A · 1 location(s) · Osijek University Hospital · NCT05181696Impact of Post-ARDS Covid-19 Sedation on Persistent Neuroinflammation
Phase N/A · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT05233605Incentive Spirometry to Improve Outcomes in Lung Cancer Patients Undergoing Concurrent Chemotherapy and Radiation Therap
NA · 1 location(s) · The Cooper Health System · NCT06688422LUNG INFECTION in ICU (LUNG-I3)
Phase N/A · 1 location(s) · BioMérieux · NCT06073834Medical Herbs Inhibit Inflammation Directing T Cells to Kill the COVID-19 Virus (COVID)
Phase 1/Phase 2 · 1 location(s) · All Natural Medicine Clinic, LLC · NCT04790240Ventilation Imaging to Improve the Quality of Life for Patients With Lung Cancer Treated With Radiation Therapy
Phase 3 · 1 location(s) · University of Sydney · NCT06127654UNC Pleural Fluid Registry
Phase N/A · 1 location(s) · UNC Lineberger Comprehensive Cancer Center · NCT05620329Residual Exacerbations With Mepolizumab
Phase N/A · 1 location(s) · Laval University · NCT04578171Targeting Inflammation With Losartan to Improve Response to Modulator Therapy in Cystic Fibrosis.
Phase 2 · 1 location(s) · University of Kansas Medical Center · NCT06364176Depemokimab Asthma Imaging and Bronchoscopy Sub-Study
Phase 3 · 50 location(s) · GlaxoSmithKline · NCT06979323Study on Safety and Efficacy of Two Doses of PRS CK STORM in the Modulation of the Cytokine Storm in Patients With Acute
Phase 1/Phase 2 · 3 location(s) · PEACHES BIOTECH · NCT06684379Functional Lung Avoidance SPECT-guided Radiation Therapy of Lung Cancer
NA · 2 location(s) · University of Aarhus · NCT04676828A Study Assessing the Effect of Dupilumab on Inducing Clinical Remission in Asthma
Phase 3 · 5 location(s) · Université de Sherbrooke · NCT07309614An Efficacy and Safety Study of DFL24498 in the Treatment of AKC
Phase 3 · 19 location(s) · Dompé Farmaceutici S.p.A · NCT07395232Cell Therapy With Treg Cells Obtained From Thymic Tissue (thyTreg) to Control the Immune Hyperactivation Associated With
Phase 1/Phase 2 · 1 location(s) · Hospital General Universitario Gregorio Marañon · NCT06052436Study of Progression of Community Acquired Pneumonia in the Hospital in Patients With More Severe Preexisting Diseases a
Phase N/A · 10 location(s) · Pneumonia Research Network on Genetic Resistance and Suscept · NCT05688774Prognostic Value of Right Ventricular-pulmonary Arterial Coupling Assessed by Echocardiography in Septic Patients
Phase N/A · 1 location(s) · University Medical Center Ho Chi Minh City (UMC) · NCT06887140Single-cell Sequencing of BLF to Guide the Treatment of Radiation Pneumonitis or Immune Checkpoint Inhibitor Pneumonitis
Phase 1/Phase 2 · 1 location(s) · Xinqiao Hospital of Chongqing · NCT05455034The APS Phenotyping Study
Phase N/A · 20 location(s) · Vanderbilt University Medical Center · NCT06521502Precision Therapy for Solid Tumors: Synergistic CDK4/6 Inhibition and Anti-VEGF Targeting LncRNA
Phase 1 · 2 location(s) · Lebanese University · NCT06307249Validation of Hematological Indices
NA · 1 location(s) · Petrovsky National Research Centre of Surgery · NCT06476171P4O2 ILD Extension
Phase N/A · 1 location(s) · Amsterdam UMC, location VUmc · NCT06644144Understanding Inflammation, InFection and Interventions in Severe Exacerbations of Cystic Fibrosis
Phase N/A · 6 location(s) · Alexander Horsley · NCT07484607Toxicity Markers to Trastuzumab-Deruxtecan (T-DXd) In Patients With Advanced Breast Cancer
Phase N/A · 1 location(s) · European Institute of Oncology · NCT07049133Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and T
Phase 3 · 159 location(s) · GlaxoSmithKline · NCT06961214Epidemiological, Clinical and Biological Characteristics of Human Anaplasmosis Cases in Alsace
Phase N/A · 1 location(s) · University Hospital, Strasbourg, France · NCT07312474PREDICATE Trial For Respiratory Tract Infections
Phase 3 · 1 location(s) · The University of Hong Kong · NCT06472219
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.